Michael Fernandez

Michael Fernandez discloses dealings in Pediatrix Medical Group, Inc. to SEC (Form 4). In total, 11 filings cover trades dated from 1 June 2016 to 13 February 2020.

Every open-market trade on record is a purchase: 6 purchases worth €9.6M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants.

A typical purchase (the median) is worth €1.2M. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +18.2%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 18 February 2020 with a share grant in Pediatrix Medical Group, Inc. The most recent open-market purchase was published on 13 August 2019, 2,628 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.